[Management of infections in neutropenia].
D000380:Agranulocytosis / Q000150:complications*; D001424:Bacterial Infections / Q000188:drug therapy / Q000628:therapy*; D002228:Carbenicillin / Q000627:therapeutic use; D003428:Cross Infection; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D007958:Leukocyte Count; D009181:Mycoses / Q000628:therapy*; D009503:Neutropenia / Q000150:complications* / Q000276:immunology; D010357:Patient Isolators; D010587:Phagocytosis; D010714:Phosphatidylethanolamines / Q000627:therapeutic use; D013752:Tetracycline / Q000627:therapeutic use
D005839:Gentamicins; D010714:Phosphatidylethanolamines; D013752:Tetracycline; D002228:Carbenicillin
Zasady zwalczania zakazeń w neutropeniach